Abstract: Provided is a method for producing biodiesel fuel having an excellent oxidative stability and fluidity at low temperature, wherein the method provides selective hydrogenation of a poly-unsaturated fatty acid alkyl ester to the mono-unsaturated fatty acid alkyl ester while inhibiting the formation of the trans-isomer, and a biodiesel fuel composition. In the method for producing biodiesel fuel, a fatty acid alkyl ester prepared from fat and/or waste edible oil by transesterification reaction, and/or (2) a fatty acid alkyl ester treated by esterification reaction of a fatty acid is hydrogenated in the presence of a hydrogenation catalyst containing at least one of noble metals selected from those of Groups 8-10 in the periodic table under low hydrogen pressure.

Abstract: A monitor program executes a set of client processes upon reboot of a computer, starts, stops and monitors client processes running on the computer, and/or detects and recovers automatically from process crashes. The program monitors a client process using a supervisory thread it creates when the client process is started, and uses the process's handle to detect its termination. When process termination is detected, the state table within the monitor program is checked to determine if the client process crashed or was exited normally. If the exit was the result of a crash, the program can automatically execute crash recovery using a preconfigured plan.

Abstract: A monitor program executes a set of client processes upon reboot of a computer, starts, stops and monitors client processes running on the computer, and/or detects and recovers automatically from process crashes. The program monitors a client process using a supervisory thread it creates when the client process is started, and uses the process's handle to detect its termination. When process termination is detected, the state table within the monitor program is checked to determine if the client process crashed or was exited normally. If the exit was the result of a crash, the program can automatically execute crash recovery using a preconfigured plan.

Abstract: A monitor program executes a set of client processes upon reboot of a computer, starts, stops and monitors client processes running on the computer, and/or detects and recovers automatically from process crashes. The program monitors a client process using a supervisory thread it creates when the client process is started, and uses the process's handle to detect its termination. When process termination is detected, the state table within the monitor program is checked to determine if the client process crashed or was exited normally. If the exit was the result of a crash, the program can automatically execute crash recovery using a preconfigured plan.

Abstract: An antacid and laxative tablet comprising magnesium oxide particles as an effective component, wherein (i) the magnesium oxide particles contained in the tablet have an average secondary particle diameter measured by a laser diffraction scattering method of 0.5 to 10 ?m, (ii) the content of magnesium oxide particles in the tablet is 88 wt % or more, (iii) the tablet does not become blackish and has substantially no tableting spot, and (iv) the disintegration time is 10 sec or less. The antacid and laxative tablet of the present invention has a high content of magnesium oxide particles, a short disintegration time, does not become blackish, has no tablet trouble and no tableting spot and is suitably administered orally.

Abstract: An antacid and laxative tablet comprising magnesium oxide particles as an effective component, wherein

Abstract: A composition for percutaneous drug administration which contains a compound of the general formula ##STR1## wherein R.sub.1 is a hydrogen atom or an alkyl group and R.sub.2 is a residue of aliphatic hydrocarbon.The composition is capable of promoting percutaneous drug absorption.

Abstract: A composition for percutaneous administration containing a nicotinic ester represented by formula (I) ##STR1## or an isonicotinic ester represented by formula (II) ##STR2## wherein R and R' each represents an alkyl group having 5 or more carbon atoms,with or without a specific polar compound. The composition improves percutaneous absorption of an active ingredient.